Loading…

Response of Hemopoietic, Progenitor, and Multipotent Mesenchymal Stromal Cells to Administration of Ketanserin during Pulmonary Fibrosis

We studied the effect of ketanserin on hemopoietic progenitor cells (Lin − Sca-1 + c-Kit + CD34– and Lin − Sca-1 + c-Kit + CD34 + ), progenitor hemopoietic cells (Lin − Sca-1 + c-kit + ), and multipotent mesenchymal stromal cells (CD45 − CD73 + CD106 + ) in C57Bl/6 mice during pulmonary fibrosis. It...

Full description

Saved in:
Bibliographic Details
Published in:Bulletin of experimental biology and medicine 2014-11, Vol.158 (1), p.21-26
Main Authors: Dygai, A. M., Skurikhin, E. G., Pershina, O. V., Stepanova, I. E., Khmelevskaya, E. S., Ermakova, N. N., Reztsova, A. M., Krupin, V. A., Reikhart, D. V., Goldberg, V. E.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We studied the effect of ketanserin on hemopoietic progenitor cells (Lin − Sca-1 + c-Kit + CD34– and Lin − Sca-1 + c-Kit + CD34 + ), progenitor hemopoietic cells (Lin − Sca-1 + c-kit + ), and multipotent mesenchymal stromal cells (CD45 − CD73 + CD106 + ) in C57Bl/6 mice during pulmonary fibrosis. It was shown that the blocker of 5-HT 2A receptors lowers the activity of bleomycin-induced inflammation in the lungs and prevents the infiltration of alveolar interstitium and alveolar ducts by hemopoietic stem and hemopoietic progenitor cells; in this case, they are more numerous in the bone marrow of sick animals. Ketanserin reduces the capacity for self-renewal of lung multipotent mesenchymal stromal cells in the fibrotic phase of the disease and inhibits their differentiation into stromal cell lines (adipocytes, chondrocytes, and fibroblasts) simultaneously with the decrease in the percentage of connective tissue in the lung parenchyma.
ISSN:0007-4888
1573-8221
DOI:10.1007/s10517-014-2682-y